Healthleap Raises $38M for AI That Flags At-Risk Hospital Patients
Healthleap closed an $8M seed round co-led by Sequoia Capital and First Round Capital, plus a $30M Series A led by Hummingbird Ventures.
Healthleap has raised $38 million in seed and Series A funding for its AI platform, which flags hospital patients at risk of undiagnosed illnesses, according to TechCrunch.
The seed round totaled $8 million and was co-led by Sequoia Capital and First Round Capital. The Series A came to $30 million and was led by Hummingbird Ventures.
Healthleap said its platform is deployed in more than 50 hospitals. Its customers include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist and Emory Healthcare.
The company said its revenue has grown more than 10x over the past year. It plans to spend the new funding on engineering, product, sales and customer success, and aims to cover more than 40 major health conditions and expand into outpatient and home care.
From clinical nutrition tool to general-purpose platform
Healthleap was founded in South Africa in 2022 by siblings Jemima and Josiah Meyer. It initially offered a clinical nutrition tool built for dietitians before pivoting to a general-purpose platform, and grew from three hospital partners to more than 50 over the past year. At the Hospital of the University of Pennsylvania, Healthleap says its malnutrition program resulted in $23.8 million in annualized financial impact.
Quick answers
How much did Healthleap raise?
Healthleap raised $38 million in total: an $8 million seed round and a $30 million Series A.
Who led Healthleap's funding rounds?
The seed round was co-led by Sequoia Capital and First Round Capital, and the Series A was led by Hummingbird Ventures.
Which hospitals use Healthleap?
Healthleap's platform is deployed in more than 50 hospitals, with customers including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist and Emory Healthcare.